DEFERASIROX
Generic: DEFERASIROX
Cipla USA Inc.Manufacturer
ORALRoute
DEFERASIROXActive Substance
2022-02-23Original Approval
DEFERASIROX is FDA application ANDA215026, sponsored by CIPLA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
SICKLE CELL ANAEMIA WITH CRISIS
363 reports
2
DEATH
191 reports
3
PYREXIA
181 reports
4
OFF LABEL USE
174 reports
5
DIARRHOEA
173 reports
6
DRUG INEFFECTIVE
162 reports
7
NAUSEA
137 reports
8
VOMITING
131 reports
9
ANAEMIA
123 reports
10
THERAPY INTERRUPTED
121 reports